Changmugu

About Changmugu

Changmugu, also known as Beijing Longwood Valley Medical Technology, is a high-tech enterprise specializing in artificial intelligence solutions for orthopedic surgery. Founded in 2018, the company is headquartered in the Beijing Economic-Technological Development Area. The company's chairman is Zhang Yiling.

Changmugu develops and provides an integrated intelligent surgical platform for hospital orthopedics departments. This platform covers the entire surgical workflow, from AI-assisted diagnosis and personalized pre-operative planning to surgical robots and post-operative evaluation. Its core product, the AIJOINT system, is an AI-powered solution for joint replacement procedures, including hip (AIHIP) and knee (AIKNEE) replacements. This system utilizes AI algorithms and 3D modeling based on patient CT scans to create precise surgical plans, helping to improve the accuracy, standardization, and safety of operations. The company's AIJOINT software has received regulatory approval in China, the U.S., and Europe. In addition to software, Changmugu is developing surgical robots, such as the ROPA (Robotic Physician Assistant), to execute the intelligent surgical plans.

The company serves a large market, with its technology applied in over 1,000 hospitals across China. Changmugu has established strategic partnerships with major industry players, including a collaboration with Johnson & Johnson Medical China to co-develop and promote digital orthopedic solutions. The business model focuses on providing these advanced MedTech solutions to hospitals, addressing the high demand for joint replacement surgeries, which exceeds one million annually in China.

Changmugu has successfully raised significant capital through multiple funding rounds, securing a total of $103 million. A Series B financing round in late 2021 raised 540 million yuan (approximately $84.3 million), co-led by prominent investors such as CICC Capital, IDG Capital, and CDH Investments. These funds are allocated to accelerate the R&D of new products, clinical trials, production expansion, and global marketing efforts.